EXHIBIT 10.6 CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. DEVELOPMENT, SUPPLY AND LICENSE AGREEMENT This DEVELOPMENT SUPPLY AND LICENSE AGREEMENT ("Agreement") is made as...Development, Supply and License Agreement • April 27th, 2004 • Oasis Semiconductor Inc • Semiconductors & related devices • Delaware
EX-10.24 5 a2210174zex-10_24.htm EX-10.24 ***Confidential treatment requested pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. Omitted portions have been filed separately with the Commission. Smith –...Development, Supply, and License Agreement • May 5th, 2020 • New York
THIS AGREEMENT (“Agreement”) is dated this 1st day of Jan, 2011 (the “Effective Date”), by and between Smith Electric Vehicles US Corp of 12200 N.W. Ambassador Drive, Kansas City, MO 64163, USA (“Smith”), and Sensor-Technik UK Ltd, and Affiliates of Unit I, Stoke Mill, Mill Road, Sharnbrook, Bedfordshire, MK44 INN, UK (“Sensor-Technik”) (collectively the “Parties,” and each individually a “Party”), based upon the following recitals.
Where LocatedDevelopment, Supply and License Agreement • March 16th, 2006
Number Description Form No. No. Filing Date Herewith 10.29†† Development, Supply and License Agreement dated S-1/A 333- 10.8 02/27/1998 September 29, 1997 between the registrant and General Instrument Corporation, formerly known as NextLevel Systems, Inc. 45619 10.30†† Amendment dated November 22, 2000 to 10-K 000- 10.16 04/02/2001 Development, Supply and License Agreement between the registrant and General Instrument Corporation. 23993 10.31†† Product Purchase Agreement dated November 22, 10-Q 000- 10.1 05/15/2002 2000, together with Amendment dated January 1, 2002, to Product Purchase Agreement between the registrant and General Instrument Corporation. 23993 10.32†† Second Amendment dated December 3, 2002 to 10-K 000- 10.22 03/31/2003 Product Purchase Agreement between the registrant and General Instrument Corporation. 23993 10.33†† Third Amendment dated as of January 1, 2003 to 8-K 000- 99.1 04/16/2004 Product Purchase Agreement be
DEVELOPMENT, SUPPLY, AND LICENSE AGREEMENTDevelopment, Supply, and License Agreement • April 4th, 2012 • Smith Electric Vehicles Corp. • Motor vehicles & passenger car bodies • New York
DEVELOPMENT, SUPPLY, AND LICENSE AGREEMENTDevelopment, Supply, and License Agreement • April 4th, 2012 • Smith Electric Vehicles Corp. • Motor vehicles & passenger car bodies • New York
THIS AGREEMENT (“Agreement”) is dated this 30th day of September, 2010 (the “Effective Date”), by and between Smith Electric Vehicles US Corp., a Delaware Corporation (“Smith”), and Clean Power Technical Solutions Sp. z.o.o., a Polish company, (“CPTS”) (collectively the “Parties,” and each individually a “Party”), based upon the following recitals.
Confidential treatment has been requested as to certain portions of this document. Each such portion, which has been omitted herein and replaced with a series of three asterisks in brackets [***], has been filed separately with the Securities and...Development, Supply and License Agreement • December 11th, 2009 • AdvanSource Biomaterials Corp • Surgical & medical instruments & apparatus
We refer to the Development, Supply and License Agreement, dated November 11, 1992 (the “Original Agreement’), by and between AdvanSource Biomaterials, Corp. (formerly known as CardioTech International, Inc. and Polymedica Industries, Inc.) (“AdvanSource”) and Bard Access Systems, Inc. (“Bard”), as amended by the Amendment to Development, Supply and License Agreement, dated January 26, 1999 (the “Amendment”) between AdvanSource and Bard, and as modified by the letter agreement between Bard and AdvanSource dated October 30, 2001 (the “First Letter’), the letter agreement between Bard and AdvanSource dated July 1, 2003 (the “Second Letter”) and the letter agreement between Bard and AdvanSource dated April 1, 2004 (the “Third Letter”). The Original Agreement, the Amendment, the First Letter, the Second Letter and the Third Letter are referred to herein collectively as the “Agreement”. Capitalized terms used herein but not defined herein shall have the meanings given such terms in the Agre
Confidential treatment has been requested as to certain portions of this document. Each such portion, which has been omitted herein and replaced with a series of three asterisks in brackets [***], has been filed separately with the Securities and...Development, Supply and License Agreement • July 1st, 2009 • AdvanSource Biomaterials Corp • Surgical & medical instruments & apparatus
We refer to the Development, Supply and License Agreement, dated November 11, 1992 (the “Original Agreement’), by and between AdvanSource Biomaterials, Corp. (formerly known as CardioTech International, Inc. and Polymedica Industries, Inc.) (“AdvanSource”) and Bard Access Systems, Inc. (“Bard”), as amended by the Amendment to Development, Supply and License Agreement, dated January 26, 1999 (the “Amendment”) between AdvanSource and Bard, and as modified by the letter agreement between Bard and AdvanSource dated October 30, 2001 (the “First Letter’), the letter agreement between Bard and AdvanSource dated July 1, 2003 (the “Second Letter”) and the letter agreement between Bard and AdvanSource dated April 1, 2004 (the “Third Letter”). The Original Agreement, the Amendment, the First Letter, the Second Letter and the Third Letter are referred to herein collectively as the “Agreement”. Capitalized terms used herein but not defined herein shall have the meanings given such terms in the Agre
